Original Article
Title: COVID-19 symptoms are attenuated in atopic dermatitis
patients treated with dupilumab
Short running title: Reduced COVID-19 symptoms in
dupilumab-treated AD
Authors: Benjamin Ungar, MD1; Jacob W.
Glickman, MD1*; Alexandra Golant,
MD1*; Celina Dubin, BA1; Olga
Marushchak, MA1,2; Alyssa Gontzes,
BS1; Daniela Mikhaylov, BA1; Giselle
K. Singer, BS1; Danielle Baum, RN1;
Nancy Wei, BA1; Diana Gruenstein,
BA1; Mark G. Lebwohl, MD1; Ana B.
Pavel, PhD1,3; Emma Guttman-Yassky, MD,
PhD1
- Department of Dermatology and Laboratory of Inflammatory Skin
Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Touro College of Osteopathic Medicine, New York, NY, USA
- Department of Biomedical Engineering, The University of Mississippi,
University, MS, USA
*Authors contributed equally